Latest Aceto Corp (ACET) Headlines
14.2% Return Seen to Date on SmarTrend Aceto Call (ACET)
Comtex SmarTrend(R) - Thu Mar 06, 11:15AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on January 24th, 2014 at $21.81. In approximately 1 month, Aceto has returned 14.19% as of today's recent price of $18.71.
Aceto Down 16.3% Since SmarTrend Downtrend Call (ACET)
Comtex SmarTrend(R) - Thu Feb 27, 9:48AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on January 24th, 2014 at $21.81. In approximately 1 month, Aceto has returned 16.26% as of today's recent price of $18.26.
ACETO Appoints Carlos Restrepo to Lead Performance Chemicals
GlobeNewswire - Wed Feb 26, 8:46AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has appointed Carlos Restrepo as Senior Vice President, Performance Chemicals, effective February 24, 2014. Mr. Restrepo will report directly to Salvatore J. Guccione, CEO of ACETO.
Shares of ACET Down 17.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 10, 9:24AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on January 24th, 2014 at $21.81. In approximately 2 weeks, Aceto has returned 17.91% as of today's recent price of $17.90.
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 07, 5:24PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Aceto Corporation's Shares Dropped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri Feb 07, 3:09PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of pharmaceutical distributor Aceto...
ACETO Corporation Revenue Estimates Incorrectly Reported Due to Third-Party Error
GlobeNewswire - Fri Feb 07, 8:28AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today that financial media outlets are misreporting that the Company missed revenue forecasts by $30.5 million. In fact, second quarter revenues increased 2.2% over the prior year period to $116.5 million. This was $2.7 million below the correct estimate as opposed to the incorrect $30.5 million reported. Earnings of $0.24 per share were in line with estimates and an increase of 41% over last year's comparable quarter. The Company is working with Thomson Reuters which expects to correct its acknowledged error within 24-48 hours.
ACETO Corporation's board to pay USD0.06 per share dividend
M2 - Fri Feb 07, 6:38AM CST
The board of directors of ACETO Corporation (ACET), a supplier of products for human health, on Thursday declared a regular quarterly dividend of USD0.06 per share of the company's common stock.
ACETO Reports Second Quarter Fiscal 2014 Financial Results
GlobeNewswire - Thu Feb 06, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2014 ended December 31, 2013.
ACETO Board of Directors Declares Quarterly Cash Dividend
GlobeNewswire - Thu Feb 06, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on March 28, 2014 to shareholders of record as of March 13, 2014.
Critical Alerts For Altria Group, ASML, Aceto, Sohu.com, and Gentex Released By InvestorsObserver
PR Newswire - Thu Feb 06, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MO, ASML, ACET, SOHU, and GNTX.
ACETO Corporation Schedules Fiscal 2014 Second Quarter Financial Results News Release and Conference Call
GlobeNewswire - Mon Jan 27, 9:02AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2014 ended December 31, 2013 after the stock market close on Thursday, February 6, 2014.
Aceto Up 46.7% Since SmarTrend Uptrend Call (ACET)
Comtex SmarTrend(R) - Wed Jan 22, 11:05AM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 4 months, Aceto has returned 46.75% as of today's recent price of $23.23.
YieldBoost Aceto Corp. To 15.5% Using Options
StockOptionsChannel.com - Wed Jan 22, 10:32AM CST
Shareholders of Aceto Corp. looking to boost their income beyond the stock's 1% annualized dividend yield can sell the August covered call at the $25 strike and collect the premium based on the $1.90 bid, which annualizes to an additional 14.5% rate...
Uptrend Call Working As Aceto Stock Rises 46.8% (ACET)
Comtex SmarTrend(R) - Wed Jan 15, 9:44AM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 4 months, Aceto has returned 46.81% as of today's recent price of $23.24.
Shares of ACET Up 48.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 08, 9:14AM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 4 months, Aceto has returned 48.01% as of today's recent price of $23.43.
Aceto Shares Up 58.0% Since SmarTrend's Buy Recommendation (ACET)
Comtex SmarTrend(R) - Tue Dec 31, 4:54PM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 3 months, Aceto has returned 57.99% as of today's recent price of $25.01.
14.2% Return Seen to Date on SmarTrend Aceto Call (ACET)
Comtex SmarTrend(R) - Thu Mar 06, 11:15AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on January 24th, 2014 at $21.81. In approximately 1 month, Aceto has returned 14.19% as of today's recent price of $18.71.
Aceto Down 16.3% Since SmarTrend Downtrend Call (ACET)
Comtex SmarTrend(R) - Thu Feb 27, 9:48AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on January 24th, 2014 at $21.81. In approximately 1 month, Aceto has returned 16.26% as of today's recent price of $18.26.
ACETO Appoints Carlos Restrepo to Lead Performance Chemicals
GlobeNewswire - Wed Feb 26, 8:46AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has appointed Carlos Restrepo as Senior Vice President, Performance Chemicals, effective February 24, 2014. Mr. Restrepo will report directly to Salvatore J. Guccione, CEO of ACETO.
Shares of ACET Down 17.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Feb 10, 9:24AM CST
SmarTrend identified a Downtrend for Aceto (NASDAQ:ACET) on January 24th, 2014 at $21.81. In approximately 2 weeks, Aceto has returned 17.91% as of today's recent price of $17.90.
Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 07, 5:24PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Aceto Corporation's Shares Dropped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri Feb 07, 3:09PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of pharmaceutical distributor Aceto...
ACETO Corporation Revenue Estimates Incorrectly Reported Due to Third-Party Error
GlobeNewswire - Fri Feb 07, 8:28AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today that financial media outlets are misreporting that the Company missed revenue forecasts by $30.5 million. In fact, second quarter revenues increased 2.2% over the prior year period to $116.5 million. This was $2.7 million below the correct estimate as opposed to the incorrect $30.5 million reported. Earnings of $0.24 per share were in line with estimates and an increase of 41% over last year's comparable quarter. The Company is working with Thomson Reuters which expects to correct its acknowledged error within 24-48 hours.
ACETO Corporation's board to pay USD0.06 per share dividend
M2 - Fri Feb 07, 6:38AM CST
The board of directors of ACETO Corporation (ACET), a supplier of products for human health, on Thursday declared a regular quarterly dividend of USD0.06 per share of the company's common stock.
ACETO Reports Second Quarter Fiscal 2014 Financial Results
GlobeNewswire - Thu Feb 06, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2014 ended December 31, 2013.
ACETO Board of Directors Declares Quarterly Cash Dividend
GlobeNewswire - Thu Feb 06, 4:00PM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on March 28, 2014 to shareholders of record as of March 13, 2014.
Critical Alerts For Altria Group, ASML, Aceto, Sohu.com, and Gentex Released By InvestorsObserver
PR Newswire - Thu Feb 06, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for MO, ASML, ACET, SOHU, and GNTX.
ACETO Corporation Schedules Fiscal 2014 Second Quarter Financial Results News Release and Conference Call
GlobeNewswire - Mon Jan 27, 9:02AM CST
ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2014 ended December 31, 2013 after the stock market close on Thursday, February 6, 2014.
Aceto Up 46.7% Since SmarTrend Uptrend Call (ACET)
Comtex SmarTrend(R) - Wed Jan 22, 11:05AM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 4 months, Aceto has returned 46.75% as of today's recent price of $23.23.
YieldBoost Aceto Corp. To 15.5% Using Options
StockOptionsChannel.com - Wed Jan 22, 10:32AM CST
Shareholders of Aceto Corp. looking to boost their income beyond the stock's 1% annualized dividend yield can sell the August covered call at the $25 strike and collect the premium based on the $1.90 bid, which annualizes to an additional 14.5% rate...
Uptrend Call Working As Aceto Stock Rises 46.8% (ACET)
Comtex SmarTrend(R) - Wed Jan 15, 9:44AM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 4 months, Aceto has returned 46.81% as of today's recent price of $23.24.
Shares of ACET Up 48.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 08, 9:14AM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 4 months, Aceto has returned 48.01% as of today's recent price of $23.43.
Aceto Shares Up 58.0% Since SmarTrend's Buy Recommendation (ACET)
Comtex SmarTrend(R) - Tue Dec 31, 4:54PM CST
SmarTrend identified an Uptrend for Aceto (NASDAQ:ACET) on September 24th, 2013 at $15.83. In approximately 3 months, Aceto has returned 57.99% as of today's recent price of $25.01.
